Wednesday 22 May 2024

Response Plus Holding's FY 2023 net profit up 68pc

ABU DHABI, March 23, 2024

Response Plus Holding, a key pre-hospital care and emergency medical services provider in the UAE and Saudi Arabia, has reported solid growth for FY 2023 with the group’s net profit surging by 68% to AED49.39 million ($13.4 million) from the previous year's figures of AED29.31 million ($7.9 million).
Announcing its audited financial results for the period ending December 31, 2023, Response Plus Holding said the group’s revenue increased to AED345.36 million as of December 31, 2023 against AED320.86 million a year ago.
Similarly, the Group’s equity soared to AED230.04 million as of December 31, 2023 from AED222.9 million the previous year.
The Earnings Per Share (EPS) increased to AED 0.25 in 2023 from AED 0.15 a year before, reflecting the group’s commitment to profitability and shareholder value creation.
The surge in the net profit and revenue illustrates the group’s growth strategy, strong performance across its business verticals, and expansion in the UAE and region, coupled with its commitment to cost optimisation, efficiency, and productivity across its operations.
On the solid results, Chairman Omran Al Khoori said: "The robust performance of Response Plus Holding during 2023 demonstrates the success of our diversified operations in the UAE, KSA, and around the region. We are confident of delivering on our solid foundation in the years to come, and accelerate our growth trajectory by deepening our expertise across pre-hospital care and emergency medical services."
"This year’s dynamic growth positions us to drive future expansion across new markets in the region and beyond," he stated.
Last year, the group had expanded its geographical presence in the region throughits key unit Response Plus Medical Complex (RPMC) in Dammam, Saudi Arabia, the first specialised private occupational healthcare centre in KSA. 
During the year, RPM Projects won contracts for 100 site clinics. The Group also achieved its Emiratisation targets and received JCI accreditation for ambulatory care services at Adnoc site clinics during 2023.
CEO Dr Rohil Raghavan said: "The Group’s strong performance during 2023 is a testament to our commitment to excellence across our operations, as well as our strategy to develop new strategic partnerships in the region and beyond. We are looking at expanding our services into different business verticals in pre-hospital care, and focusing on operational synergies and cost efficiencies."
"We are well positioned for a strong growth trajectory in the coming years, driven by the vision of our leadership and board, supported by our team’s expertise, and backed by the trust of our shareholders." he added.-TradeArabia News Service


More Health & Environment Stories

calendarCalendar of Events